RUNX2 and breast cancer: Compared to untreated breast cancer cells, treated breast cancer cells increased their expression of osteoblast cadherin CDH11, RUNX2, osteonectin (SPARC), the bone matrix-remodeling protein periostin, as well as a defined set of “bone-related genes”.